JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit www.jenavalve.com for more information.
Company Growth (employees)